Marquette University

e-Publications@Marquette
Physical Therapy Faculty Research and Publications

Health Sciences, College of

9-1-1991

Improved Healing of Pressure Ulcers Using
Dermapulse, A New Electrical Stimulation Device
Gary D. Gentzkow
Staodynamics Inc

Sheldon V. Pollack
University of Toronto

Luther C. Kloth
Marquette University, luther.kloth@marquette.edu

Harrison A. Stubbs
University of California at Berkeley

Published version. Wounds, Vol. 3, No. 5 (September/October 1991): 158-170. Publisher Link.
© 2012, HMP Communications, LLC. All rights reserved. Reproduction in whole or in part
prohibited. Opinions expressed by authors, contributors, and advertisers are their own and not
necessarily those of HMP Communications, LLC, the editorial staff, or any member of the editorial
advisory board. HMP Communications, LLC is not responsible for accuracy of dosages given in
articles printed herein. HMP Communications, LLC disclaims responsibility for any injury to
persons or property resulting from any ideas or products referred to in the articles or advertisements.
Content may not be reproduced in any form without written permission. Reprints of articles are
available. Contact HMP Communications, LLC for information. HMP’s products include peerreviewed and non-peer-reviewed medical journals, national trade shows and conferences, online
programs and customized clinical programs. HMP is wholly owned subsidiary of HMP

Improved Healing of Pressure
Ulcers Using Dermapulse, A New
Electrical Stimulation Device
Gary D. Gentzkow, MDl
Sheldon V. Pollack, MD, FRCP, FACPz
Luther C. Kloth, MS, PT3
Harrison A. Stubbs, PhD4
ABSTRACT: A double-blind, clinical study of pulsed electrical stimulation using the
Dermapulse® device was carried out on 40 pressure ulcers, randomized to receive either active
(stim) or sham treatment.
Electrodes were placed over saline-moistened gauze on the ulcers. An electrical current of 35mA
was delivered to the wound tissues at a frequency of 128 pulses per second. Polarity was negative
until the wound debrided, then alternated from .positive to negative every three days. Ulcers were
treated for 30 minutes twice daily for four weeks, after which sham patients could cross over to
active treatment, and stim patients could continue active treatment. Ulcer healing was determined
by measuring the length and width of the ulcer and calculating the L x W product. The same clinicians measured the ulcers each week, were kept blinded to treatment group, and were not the same
persons who applied the treatment.
Nine centers treated 40 ulcers (19 sham and 21 stim). Analysis of the characteristics of the
patients, the ulcers, and concomitant wound care by both univariate and multivariate analyses
showed comparability of the groups. After four weeks, the stim ulcers healed more than twice as
much as the sham ulcers (49.8% vs. 23.4%; (p = 0.042). The stim ulcers healed 12.5% per week compared to 5.8% for the sham group. In the 15 crossover patients, four weeks of active stimulation
caused nearly four times as much healing as their four weeks of sham treatment (47.9% vs. 13.4%;
p = 0.012). By the last week of-active stimulation they had healed an average of 64%, and complete
healing occurred in 40% of these ulcers after an average of nine weeks. Seventeen of the active treatment ulcers had extended therapy, and by their last week of treatment had healed an average of
75%. Forty-one percent of these ulcers healed completely after an average of 11.8 weeks. There were
no significant safety problems identified.
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Pressure ulcers are a major healthcare problem in the United States. The National Pressure
Ulcer Advisory Panel, based on the available
literature, estimated the prevalence of pressure
ulcers among hospitalized patients to be
between 3% and 14%, among patients in long
term care settings between 15% and 25%, and
between 7% and 12% in home care settings.l
This translates to more than one million cases,
and possibly two million cases of pressure

WOUNDS: A Compendium of Clinical Research and Practice

GENTZKOW, et al.

ulcers in the U.S.l Various studies estimate the
cost to heal one ulcer to be from $5,000 to more
than $25,000, and the total financial burden
runs well over five billion dollars annually.2
These wounds often heal slowly, and are associated with increased morbidity and mortality.3
Since the middle of the twentieth century,
electrical stimulation has been shown to
improve the healing of wounds in humans4-12
and experimental wounds in animal models.13-19
Cell culture studies have shown that electrical
fields can influence the migratory, proliferative,
and functional capacity of cells involved in the
healing process.20-29 Other studies have reported measurements of injury potentials, skin battery voltages, and wound lateral voltage gradients which have been theorized to trigger bioelectric repair and enhancement of wound
healing.30-38 If electrical signals play a role in
the stimulation of wound repair, then exogenous application of electric current to chronic
wounds could be expected to mimic the body's
bioelectric currents and enhance tissue healing
processes. Reports from numerous clinical and
experimental studies provide evidence in support of this idea.4-29
Because of different ways of reporting electrical output parameters, the literature at first
appears chaotic with respect to what kinds of
stimulation are effective. Reich and Tarjan
reviewed the literature on the electrical stimulation of wounds in order to determine the
range of efficacious treatment parameters.39
When they converted reported outputs to certain common parameters (current density, total
charge delivered, and average charge delivered/ cm2), they found that "successful" treatments were within certain ranges. "Effective"
treatments delivered a total charge per day
between 0.1 and 2 coulombs. It was also noted
that changing polarity during treatment was a
common procedure.
The importance of polarity was demonstrated by Davis, et al in a study of partial thickness
Wounds in pigs, in which a regimen that utilized negative followed by positive polarity
Was found to be more effective than other regimens.l6 Other animal studies showed that
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cathodal (negative polarity) electrical current
solubilizes dotted blood,30-33 confirming clinical observations that cathodal direct current
stimulation facilitates debridement of necrotic
wound tissue, which consists primarily of coalesced blood elements in a protein mesh.
Current of negative polarity has also been
shown to be most effective at increasing local
blood flow.38,39 It has also been demonstrated
that white blood cells involved in the inflammatory phase of wound healing are attracted to
the negative pole23,25 and that isolated epidermal cells, cell clusters and cell sheets migrate
toward the negative pole.2o Those interested in
a more complete review of the literature on the
effects of electrical stimulation on wound healing are referred to an upcoming article by
Gentzkow and Miller.42
Recognizing the need for new, effective
treatments for pressure ulcers and benefiting
from previous experimental work, the
Dermapulse device was developed. It was
extensively tested in animal models to optimize treatment parameters before a program of
human testing was undertaken.
Pressure ulcers are difficult to study for several reasons. There is great heterogeneity in the
size, character, location and chronicity of the
ulcers, in the basic physical state of the
patients, and in the "standard" treatments utilized. In order to obtain sufficient numbers of
ulcers to study, multicenter efforts are necessary. Furthermore, most of the patients are
elderly and ill, so that controlled trials are frequently interrupted by death, or acute illness
requiring transfer to another facility. No doubt
this is why most of the studies published on
pressure ulcer treatments are anecdotal or lack
controls, or else report on a small number of
patients.
Our randomized, controlled study was
designed to satisfy current scientific standards,
to be convincing both to federal regulators and
to clinicians, and to have enough subjects for
sound statistical analysis. At the same time, it
needed to be practical, and easy to carry out in
multiple investigational sites without unduly
complicating routines of care.
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The purpose of this study was to investigate
the safety and effectiveness of electrical stimulation using the Dermapulse device for the
treatment of pressure ulcers, as an adjunct to
standard care.

Materials and Methods
Study design. The study was carried out,
according to a common protocol, at nine investigational sites with centralized monitoring and
data analysis. After signing the informed consent, patients who met the selection criteria
were randomly assigned to receive treatment
with either an active (stim) or a sham device.
Devices were identical in appearance and were
assigned by number. Investigators and patients
were unaware of whether the device was active
or sham, and all study procedures were identical for both groups.
Patients were treated for 30 minutes twice
daily for four weeks. Four weeks was chosen as
the time for efficacy evaluation because investigators were reluctant to keep patients on
devices that might be sham for longer than
that. At the end of the four weeks, at the investigator's discretion, sham patients were
allowed to cross over to non-blinded active
treatment, and stim patients could continue to
be actively treated.
The primary measure of ulcer healing was
the relative change in size of the ulcers, determined by measuring the length and width of
the ulcer and calculating the L x W product. It
was recognized that the length x width product
only estimates the true area of an ulcer.
Nonetheless, it is quite reproducible and simple to use clinically, and it is quite useful for
monitoring changes in ulcer size (change in
size, not absolute size, was the parameter of
interest).
Subject selection. Patients were included if
they had pressure ulcers that were open and
Stage II, III or IV. Stages were defined as follows: Stage II, full thickness skin defect extending into subcutaneous tissue; Stage III, defect
extending into muscle; Stage IV, defect extend-
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ing to bone or joint structure. (Note: In the no
widely used IAET staging system, our Stage~
would be Stage III, and our Stages III and IV
would both be Stage IV.) To be included, the
ulcers were to be between 4 cm2 and 100 cm2in
area as determined by the L x W product.
Patients could have more than one ulcer
entered into the study (the ulcers had to be on
opposite sides of the body) in which case each
ulcer was randomized separately, giving the
possibility that two ulcers would both be sham
treated, both actively treated, or one of each.
Patients also had to be cooperative and available for the duration of the study, and willing
to sign an informed consent (or have a legal
representative sign for them).
Ulcers were excluded from entry into the
study if they were totally occluded by eschar,
had bleeding or involving major blood vessels;
were located in presternal, periorbital, or laryngeal/ pharyngeal regions; occurred in subjects
who were pregnant, wore a cardiac pacemaker,
had osteomyelitis or peripheral vascular problems predisposing them to thrombosis; were
cancerous; or occurred in patients who were on
long-term steroid therapy, chemotherapy, radiation therapy, or who were very obese.
Study procedures. Information on each
patient was obtained concerning age, sex,
mobility status, systemic medications, systemic
conditions, and whether they were inpatients
or outpatients.
Information on each study ulcer was
obtained regarding etiology, location, stage,
duration, past treatment, type of concomitant
wound treatment used during the study, and
presence or absence of tunnels or eschar. The
ulcers were measured for length, width, and
depth, were charted as to location, and were
diagrammed on a chart.
Conventional care was prescribed by the
physician according to the needs of the individual patient, and was recorded. In all patients,
wounds were kept hydrated with salinemoistened gauze between treatments.
The treatment regimen was chosen based on:
unpublished animal studies performed at the
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University of Miami, Johns Hopkins School of
Medicine, Duke University Medical Center,
and the Medical University of South Carolina;
and previous clinical experiences and published animal and clinical studies.4-19
The study utilized a Derrnapulse stimulator
as the device to deliver the pulsed electrical
current. Powered by a six-volt battery, this
device delivers current at pulse rate/pulse
duration settings between 2 pps/350 rnicrosec.
to 128 pps/150 rnicrosec., at intensity settings
between 0 and 150 rnA., and in either positive
or negative polarity. It has an automatic timer
that shuts off the current at the end of the
30-minute treatment.
Treatments were given twice per day for 30
minutes each, with a minimum of four and a
maximum of eight hours between treatments.
Identical procedures were followed for sham
and stirn treated ulcers.
The ulcer bed was flushed with saline solution before each treatment and kept moist with
saline solution between treatments. To enhance
conduction of electricity to the wound, clean
4 x 4 gauze pads moistened with saline solution were placed directly over or into the ulcer.
The electrode pads were composed of a carbon
silicone rubber, covered with a cellulose
sponge with an active contact area of 58 crn2.
The electrode pad was saturated with saline,
placed on top of the gauze pads and secured
into place. For large ulcers, two electrode pads
were used.
A large nontreatrnent or return electrode
was wetted and placed on a large muscle
group at a minimum distance of 12 inches from
the ulcer and secured with velcro belts.
The Dermapulse stimulator controls were set
to provide pulsed electrical stimulation at a
rate of 128 pps and an intensity of 35 rnA.
Using a 58 crn2 electrode, these stimulus
parameters delivered a charge of 0.89 coulombs
per 30 minute treatment, or 1.78 coulombs per
day, which is consistent with the delivered
energy found to be effective in other studies.39
The treatment electrode polarity was initially set as negative and remained that way until
the ulcer was debrided and a serosanguinous
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drainage appeared. Thereafter, the polarity was
switched back and forth from positive to negative every three days. When the ulcer progressed to a Stage II classification, the pulse
rate was changed to 64 pps and the pad polarity was changed each day until the ulcer was
healed.
Inpatients were treated by healthcare practitioners. For those at horne, either the patient or
a family member was trained to apply the stimulator and to document the treatment times
each day and the machine settings on the daily
treatment log.
Only trained healthcare practitioners performed the ulcer measurements, and they were
kept blinded during the four week study as to
whether the unit was sham or active. The same
clinicians measured the ulcers each week, and
they were not the same persons who applied
the treatment.
Safety was assessed daily (by inspection of
the ulcer and by recording of patient cornplaints) and a daily log of treatments was kept.
At baseline and weekly during treatment,
the clinicians diagrammed the ulcer and measured its length, width and depth, and determined if any tunnels were present. Detailed
instructions for measuring the ulcers and for
diagraming the ulcers on the data reporting
forms were provided in the protocol. The
length was measured across the longest distance of the ulcer, the width at the widest distance across the ulcer. Depth was measured at
the estimated deepest location of the ulcer, but
was used only to compare the treatment
groups at baseline.
Color photographs were taken biweekly to
provide a visual record. These were not standardized nor did they always include a scale in
the field, and they were not intended for planimetric analysis.
Patients who crossed over or had extended
therapy continued to have daily safety and
weekly efficacy assessments as long as they
were treated. Post-study follow-up was carried out weekly for four weeks for safety and
to determine if there were any problems and if
healed ulcers continued to be healed.
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Table 1. Patient and ulcer characteristics by treatment
group.
SHAM

STIM

TOTAL

Age
Mean
SD
Range
Sex
Male%
Female%

62.2
18.4
31-90

63.3
17.8
29-91

62.8
17.6
29-91

47.4
52.6

61.9
38.1

55.0
45.0

Initial Ulcer Area (cm2)
Mean
(SD)

12.5
(11.9)

19.2
(23.2)

16.0
(18.79)

Initial Ulcer Depth (em)
Mean
(SD)

1.4
(2.3)

1.1
(2.1)

1.2
(2.2)

1
14

0
16

1
30

~

2

_2_

19

21

40

6
8
1

9
4
2

Stage
II
III
IV
Total
Location
Hip /Ischium
Sacrum/ Coccyx
Leg
Foot
Total

~

_Q

19

21

15
12
3
10
40

Duration
<1 month
1 to 3
3 to 6
6 to 12
>12

%
11.1
16.7
22.2
16.7
33.3

%
20.0
5.0
25.0
35.0
15.0

%
15.8
10.5
23.7
26.3
23.7

Tunnels/Undermining
Yes
No

%
26.3
73.7

%
38.1
61.9

%
32.5
67.5

Eschar
Yes
No

%
21.1
78.9

%
28.6
71.4

%
25.0
75.0

For continuous variables such as age, dura~
tion of ulcer, and percent healed, statistical
comparisons of the stim and sham groups were
performed using the two sample Student's
t-test. This test was used with the pooled variance estim~te if there was no evidence of differences in the variances at the 5% level by
Cochran's test. Where there was evidence of
significantly different variances, the test was
employed using the separate variance estimates for the two groups with the degrees of
freedom adjusted accordingly.
For categorical variables, e.g. sex, or tunnels I undermining, the stim and sham groups
were compared using the chi square test. Yate' s
correction for continuity was used for dichotomous variables.
Stepwise multiple discriminant analysis was
employed to ascertain factors or combinations
of baseline characteristics that might distinguish the stim and sham groups.
Stepwise multiple regression analysis was
performed to explore and model the possible
effects of various factors and treatment group
on treatment outcome as indicated by percent
healed.
Three-way analysis of variance was performed to evaluate the separate effects on percent healed of investigational center or ulcer
location when considered with treatment
group and tunnels/undermining.
For crossover ulcers, the paired t-test was
used to compare the percent healed during the
four-week sham and active stimulation
periods.
For this report, all references to statistical
significance are based on the 0.05 significance
level for two-tailed tests, unless otherwise
specified.

Results

Statistical methods. It was calculated that
approximately 23 patients per group would be
needed to detect differences of 15% or more in
percent healed at four weeks, with an alpha
error of 0.05 and a power of 80%, and an estimated variance of 18%.
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Enrollment and exclusion from analysis.
Forty-nine ulcers (24 sham, 25 stim) were
enrolled into the study at nine investigational
sites. Six ulcers (4 sham, 2 stim) were excluded
from analysis because they received less than
four weeks of treatment and thus did not have
enough data for analysis. Three ulcers (1 sham,
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Table 2. Part 1
Summary of results of the statistical tests used to compare the SHAM and STIM groups of comparability of patients and ulcer
characteristics.
1 All

chi-square values for fourfold tables include Yate's correction for continuity.
adjustment for heterogeneity of variances.

2 With

Characteristics

Statistical Test

Sex
Age
Wound stage
Duration

chi-square1
t-test
chi-square
t-testz
chi-square

0.37
-0.18
1.15
1.34
4.28

1
38
2
20.94
4

0.55
0.86
0.56
0.20
0.37

Tunnels/Undermining
Initial Wound:
size (L x W)
depth

chi-square

0.21

1

0.65

t-testz
t-test

-1.18
0.44

30.46
38

0.25
0.66

Previous Treatment:
conservative
debridement
antibiotics
medication

chi-square
chi-square
chi-square
chi-square

0.81
0.45
0.02
0.09

1
1
1
1

0.37
0.50
0.88
0.76

Sytemic conditions:
cardiovascular
central nervous
metabolic
musculoskeletal

chi-square
chi-square
chi-square
chi-square

0.17
0.00
0.04
0.82

1
1
1
1

0.68
1.00
0.85
0.37

Degree of mobility

chi-square

0.29

2

0.86

In/ out patient

chi-square

0.00

1

1.00

Eschar

chi-square

0.03

1

0.86

Receiving Treatment
for other conditions:
antibiotics
diabetics
cardiovacular
psychotropic

chi-square
chi-square
chi-square
chi-square

0.03
0.02
0.00
0.32

1
1
1
1

0.86
0.88
1.00
0.57

chi-square

0.00

1

1.00

chi-square

0.00

1

1.00

Concomitant Therapy:
surgical or
whirlpool therapy
bedrest & elevation
of extremity

Test Statistic

Degree of
Freedom

Significance Value
(p-value)

Part 2.
A stepwise discriminate analysis of factors potentially differentiating the treatment groups was done
Using the characteristics listed in Part 1. None of these characteristics alone or in combination was found
to be statistically different between treatment groups at the 0.10 significance level.
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2 stim) were excluded from analysis because of

serious protocol violations which made it
impossible to analyze critical data. Patients
were not excluded for minor protocol violations, and every effort was made to include as
many patients in the analysis as possible.
Overall, 40 I 49 ulcers (19 sham, 21 stim) or
81.6% were included in the analysis. These 40
ulcers were on 37 patients; three patients each
had two ulcers included in the analysis. The
randomization resulted in approximately equal
numbers of pressure ulcers being enrolled in
the sham and stim groups overall and at each
center. Nearly equal numbers in each group are
included in the analysis as well.
Patient, ulcer, and care characteristics. Table
1 lists the key characteristics of the patients and
the ulcers for the sham and stim groups.
Patient ages ranged from 29 to 91 years. The
mean ages of the patients in the sham and stim
groups were nearly identical, 62.2 and 63.3
years respectively. Overall, there were 55%
males and 45% females, but there was a higher
proportion of females in the sham group than
the stim group (52.6% vs. 38.1 %).
The mean initial ulcer area was somewhat
larger in the stim group (19.2 vs. 12.5 cm2),
while the sham group had slightly deeper
ulcers (1.4 vs. 1.1 em). Nine of the wounds
were Stage IV, 30 were Stage III, and the only
Stage II wound was in the sham group.
Location of ulcers were: hip/ischium 15,
sacrum I coccyx 12, leg 3, and foot 10. The
ulcers were distributed similarly between the
groups. Duration of the ulcers prior to the
study was also similar in both groups, with
15.8% less than one month, 10.5% 1 to 3
months, 23.7% 3 to 6 months, 26.3% 6 to 12
months, and 23.7 greater than a year.
Tunnels I undermining of the ulcer were present somewhat more often in the stim group,
38.1% vs. 26.3%. About one-fourth of the ulcers
in each group had eschar on them at the beginning of the study.
Not shown in Table 1 are additional baseline
data. Approximately 80% of each group were
treated as inpatients. Nearly equal percentages
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of each group were bedbound (50%)
wheelchair bound (42%) or ambulatory (8%)~
There were no meaningful differences in the
type of care the ulcers had received prior to the
study, the systemic conditions of the patients,
or the drugs they were taking.
The type of concomitant ulcer care (in addition to the electrical stimulation procedures)
provided during the study was recorded, and
virtually identical percentages of sham and
stim ulcers received normal saline and dressings (100%), surgical or whirlpool debridement
(10%) turning to relieve pressure (100%), or bed
rest and elevation of an extremity (55%).
Comparability of sham and stim groups. It
is of critical importance to determine if the
active treatment (stim) and control (sham)
groups were comparable at the time of enrollment, as a check that randomization produced
comparable groups and to see if any factors
that are correlated with the healing of the
ulcers existed. Univariate and multivariate
comparisons of the groups for characteristics
for which data were gathered were performed
and are listed in Table 2. None of the variables
was significantly different between the groups,
nor did any variable even approach statistical
significance at the 0.05 or 0.10 significance
level.
It can be concluded that there was no statistical evidence of differences between the two
treatment groups at baseline and the significant
differences in treatment outcome are not likely
to be attributable to any differences in group
characteristics.
Efficacy: Four week double-blind results.
As shown in Table 3, at four weeks the stim
group had healed more than twice as much as
the sham group (49.8% vs. 23.4%), a rate of
12.5% per week versus 5.8% per week. This difference was statistically significant (p = 0.042).
Inspection of the standard deviations also
shows that the variability in healing response
was less with active treatment. Figure 1 graphically displays the rate of healing for the two
groups over the four weeks of the blinded
study.
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Table 3

PERCENT HEALED

50

Treatment
Group

Weekl
%

Week2
%

Week3 Week4
%
%

40
30

20

SHAM
(N=19)

3.7

10.2

23.1

23.4

0~~~~----~-------------

(SO)

(25.7)

(38.1)

(40.3)

(47.4)

STIM
(N= 21)

18.0

33.2

35.1

49.8

(SO)

(19.6)

PValue

10

0.053

(29.0)
0.037

(36.1)

(30.9)

0.325

0.042

SO = Standard Deviation
P values are calculated by T-Test, 38 degrees of
freedom, two-tailed

Table 3. Percentage of ulcer healed at weeks 1,2,3, and 4
for the SHAM and STIM groups. Each patient's wound
area at each week was compared to the area at baseline, and
the percentage healed was calculated. The data reported are
the mean of these individual percentages.

The foregoing univariate analysis does not
adjust for any factors other than treatment
group which might be associated with treatment outcome. Consequently, a stepwise multiple regression analysis was performed to assess
the possible simultaneous effects of various
potential co-factors on the four week mean
percentage of ulcer healed. The same characteristics of the patients, their ulcers, and concomitant wound therapy listed on Table 2 were
employed in this analysis as potential predictors of treatment outcome.
Table 4 lists the five variables that were
found to meet the 0.05 significance criterion.
The multiple regression coefficient for these
data (R = 0.751) is quite high. Not surprisingly,
treatment group was significantly associated
With outcome. Metabolic condition, having
tunnels I undermining in the ulcer, sex, and
stage of the ulcer are also associated with outcome. The fitted model derived from this analysis can be expressed as follows: The expected
percentage healed after four weeks: +41.41% if
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INITIAL

00

SHAM

WEEK 1

WEEK 2

ill

WEEK 3

WEEK4

STIM

Figure 1. The percentage of the ulcer healed (Mean +1SEM) at weeks 1,2,3, and 4 for the SHAM control group
(lower line) versus the percentage healed for the actively
treated STIM group (upper line). Each patient's wound
area at each week was compared to the area at baseline, and
the percentage healed was calculated. The data reported are
the mean of these individual percentages.

actively stimulated, +27.17% if the patient has a
metabolic condition, +26.32% if the patient is
female, -37.40% if tunnels/undermining are
present, -22.28% if Stage IV vs. III (or III vs. II).
Although none of these variables was significantly different between the treatment groups,
if there were any bias in the results due to
imbalances in the treatment groups, this would
be expected to work against finding an effect of
the active treatment because the stim group
had fewer patients with metabolic conditions
(mainly diabetes), fewer females, more tunnels,
and slightly higher stages than the sham group.
Since treatment by electrical stimulation
(treatment group) and presence of tunnels/
undermining were already determined by the
stepwise multiple regression analysis to have
major effects on healing rates, it was possible to
look at the individual effects of other categorical factors when combined with those two factors in a three-way ANOVA. Whereas treatment group and tunnels/undermining were
still found to be significantly associated with
outcome (p < 0.05), this analysis provided no
evidence of an effect on outcome due to either
anatomic location (p = 0.71) or investigational
center (p = 0.28).
Patients who crossed over from sham to
active stimulation. At the end of the four week
study period the investigators could cross over
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Table 4.

Stepwise multiple regression analysis of mean percentage of wound healed as a possible function of various factors including treatment group.

Step
1
2
3
4
5

Variable
Metabolic Condition
Treatment group
Tunnels
Sex
Stage
(constant)

Multiple R

R2

0.391
0.539
0.632
0.709
0.751

0.153
0.291
0.400
0.502
0.563

Partial R2
0.153
0.138
0.109
0.102
0.061

Coefficient*

p-value*

27.17
41.41
-37.40
26.32
-22.28
52.72

0.0227
0.0003
0.0027
0.0141
0.0419
0.1763

No other variables met the 0.05 significance level.
* as of final equation

Table 4. Results of the multiple regression analysis undertaken to determine factors associated with wound healing.

the sham ulcers to unblinded active therapy. Of
the 19 sham ulcers with analyzable four-week
data, 15 were crossed over, completed at least
four weeks of active therapy, and continued for
a mean total of 9.8 weeks (range 5 to 16 weeks)
of active stimulation. At the end of the sham
treatment period these ulcers had healed only
an average of 13.4 percent. After four weeks of
active stimulation they had healed an average
of 47.9 percent of their size at the time of
crossover. This fourfold greater healing during
four weeks of stim versus four weeks of sham
in the same ulcers is statistically significant
(p = 0.012; t-test, two-tailed).
The average healing after four weeks of
active stimulation in these ulcers (47.9%) was
almost identical to the healing after the first
four weeks (49.8%) in the active treatment
group, indicating a consistent treatment effect.
By their last week of active treatment the
crossover ulcers had healed an average of 63.9
percent. Forty percent of the ulcers healed completely, after an average of nine weeks.
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Extended therapy in active treatment
patients. Of the 21 patients in the active treatment group, 17 received additional stimulation
beyond the first four weeks of therapy. The
total duration of stimulation (including the first
four weeks) averaged 10.7 weeks, with a range
of 5 to 26 weeks. After their initial four weeks
of therapy, these patients had healed an average of 45.0%; by their last week of therapy they
had healed an average of 74.6%. Forty-one percent of the ulcers healed completely, after an
average of 11.8 weeks therapy.
Post-study follow-up. Four-week poststudy follow-up did not reveal any adverse
effects of treatment in any of the ulcers. All of
the ulcers that were completely healed during
the initial study, after crossover, or during
extended therapy were still healed at
follow-up. Three ulcers had not quite healed
during active treatment but were fully healed
upon follow-up.

WOUNDS: A Compendium of Clinical Research and Practice

GENTZKOW, et al.

Safety. There were no significant safety
problems during the study and no patient was
withdrawn because of an adverse event. The
only complaints that could be attributed to the
active treatment were uncomfortable sensations in the ulcer when the current was turned
on, which occurred in 13.6% of ulcers during
active treatment versus 4.2% of ulcers during
sham treatment.

Discussion
This double-blind, randomized, placebocontrolled, multicenter study demonstrated the
safety and effectiveness of pulsed electrical
stimulation, utilizing the Dermapulse device,
for the promotion of healing of pressure ulcers.
During the four weeks of double-blinded treatment, the stimulated ulcers healed more than
twice as much as the sham ulcers and this difference was statistically significant. Multiple
regression analysis confirmed a highly significant positive association of active stimulation
with amount of ulcer healing. These healing
rates are consistent with those reported in
other studies of electrical stimulation.4-10 In
comparing these rates of healing, it should also
be noted that these were all severe pressure
ulcers, with all but one meeting the IAET criteria of Stage IV.
Some degree of healing in the sham group
was not surprising because of the increased
care given to the ulcers as part of the study
procedures, and the maintenance of a moist
wound environment. But active treatment significantly added to this "non-specific" treatment effect. The sham group did not show any
further healing between weeks three and four,
suggesting that the "non-specific" healing
effects may have reached their maximum at
three weeks.
Controlled clinical studies of pressure ulcers
are inherently difficult. Nonetheless, this study
fulfills the generally accepted criteria for a
well-controlled trial. It was carried out in compliance with the Institutional Review Board
and Informed Consent regulations. Blinding
and randomization were done carefully and
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systematically. Investigators were trained in
study procedures and agreed to conduct the
study in compliance with FDA regulations. The
study sites were closely monitored to insure
compliance with protocol procedures and
record-keeping requirements. Problems that
arose in study conduct were identified and corrected. Analysis of data was carried out using
accepted statistical techniques and included
multiple analyses to characterize baseline and
outcome parameters.
Multivariate analysis also indicated that
metabolic condition and female sex were associated with better healing, and that presence of
tunnels I undermining and a more severe stage
of ulcer were associated with poorer healing.
To the extent that the treatment groups were
unbalanced with regard to these characteristics,
the difference favored the sham group in every
case. Based on these results, if there was any
bias in the results due to these factors it would
have been expected to work against finding an
effect of the active treatment.
One potential weakness in the study design
is the use of the length x width product to estimate wound size. In designing this study, other
techniques such as photography with planimetry and tracings were considered. In order to be
reproducible and accurate, photography
requires expensive and extensive controls. Each
center must be provided with standardized
cameras and flash units and a means of controlling exposure, lighting, and focal distance.
The angle of the photograph is critical and
variations in angle may give false data on
planimetric analysis. Wounds that curve
around a body part are especially difficult to
photograph accurately. Small changes in the
position of the patient when photographing
mobile tissue, such as the gluteal areas, can
greatly distort the wound outline. Tracing is
subject to many of these same problems, and
still requires expensive planimetric analysis.
For these reasons, we did not choose to use
these techniques in this study.
It was recognized that the length x width
product only estimates the true area of a
wound. Nonetheless, it is quite reproducible
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and simple to use clinically, and it is quite useful for monitoring changes in wound size
(change in size, not absolute size, was the
parameter of interest). If one were trying to distinguish quite small changes between treatments it would be more problematical, but the
magnitude of changes observed in this study
are quite readily measurable by this technique.
Furthermore, the photographic record, though
not adequate for planimetric analysis, at least
provided visual confirmation of the large
changes in wound size.
The results also point out that four weeks
was a long enough study period to demonstrate significantly different healing results
between the sham and stim groups, but was
not long enough in most patients to produce
complete healing. Complete healing required
nine to twelve weeks treatment on the average.
Not all ulcers were continued long enough
to determine if complete healing would occur.
The usual reason for incomplete healing in the
study was that therapy was stopped before
complete healing took place. Of necessity, the
experimental therapy, following a detailed protocol, and demanding extensive documentation, can only be carried out at specially designated investigational sites. Thus, for example,
when a nursing home patient experiences an
intercurrent illness and must go to the acute
care hospital for a few days, the study is terminated for that patient.
The treatment proved to be extremely safe.
There were no significant safety problems identified and no patient was withdrawn from the
study because of an adverse event or skin irritation. The only treatment-related adverse
events were the occurrence of uncomfortable
sensations in the ulcers at the time of treatment, which happened in 13.6% of the stim
ulcers versus 4.2% of the sham ulcers. All of
these happened only once or twice during
weeks of treatment and only at the beginning
of therapy. Since sensations were perceived by
only a minority of patients, some in each
group, and only once or twice during all of the
treatments, we do not believe this compromised the blinding.
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We conclude that in this study pulsed electrical stimulation using the Dermapulse device
was safe and effective for the promotion of
healing of pressure ulcers as an adjunct to standard ulcer care, and suggest that it may prove
to be an important addition to the care of this
important health problem.
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